5-year survival rate was 44.3 % in colorectal carcinoma ( n = 85 ) , 36.2 % in cervical cancer of uterus ( n = 35 ) , 40.6 % in renal cell carcinoma ( n = 32 ) , 50.3 % in breast cancer ( n = 23 ) , 50.0 % in testicular cancer ( n = 16 ) , 17.9 % in osteosarcoma ( n = 33 ) , 34.1 % in soft part sarcoma ( n = 38 ) .
C0029463
osteosarcoma
C1261473
sarcoma